All Biomarkers Content

Bringing you the latest research in biomarker development, diagnostics, precision medicine and more through a range of Speaker Interviews, Industry Insights, and Expert Opinions.

Insight Article
Key opinion leaders from GlaxoSmithKline and Weill Cornell Medicine discuss future perspectives on neuro-organoids.
By Tia Byer |
29 April 2022
Biomarkers for Clinical Development
Discussion Group Report
Jordi Clarimon, Lead Specialist in Fluid Biomarkers at Lundbeck, leads a discussion on ‘Fluid Biomarkers for Neurodegenerative Diseases.
By Tia Byer |
26 April 2022
Biomarkers for Clinical Development
Commentary
In this Commentary article, we investigate the applications of human stem cell modelling for identifying the ways in which neurodegenerative diseases such as Alzheimer's and Parkinson's affect the brain.
By Ben Norris |
08 April 2022
Diagnostics
Commentary
This Commentary article explores the applications of pathway mining for the identification of disease targets associated with breast cancer, where there is an unmet need for treatment. The mission is to identify the best proliferation marker for guiding the choice of systemic treatments for breast cancer.
By Ben Norris |
31 March 2022
Digital Biomarkers & Digital Pathology
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our March Discussion Group addressing ‘Translational Biomarkers to Guide Clinical Development of CAR T-Cells’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
31 March 2022
Biomarkers for Clinical Development
Insight Article
Data management for diagnostic devices is fast becoming a vital concern of the biomarkers industry. With the increased prevalence of ML and AI, this article interviews key opinion leaders from Nottingham Trent University, Apis Assay Technologies, and UCB about the future perspectives of diagnostic innovation and regulation.
By Tia Byer |
30 March 2022
Diagnostics
Commentary
Looking at how Ultivue uses spatial imaging to observe biomarkers
10 March 2022
Biomarker Technologies
Discussion Group Report
Oxford Global’s Discussion Groups provide a focused networking opportunity for a handful of like-minded experts on a monthly basis. Our February Discussion Group, focusing on ‘Using Biomarkers For Clinical Development & Regulatory Approval,’ was a tremendous success. The discussion brought together an exclusive panel of key opinion leaders to address the key factors behind the market’s growth, its priorities, future outlook, and challenges.
By Tia Byer |
28 February 2022
Biomarkers for Clinical Development
Insight Article
How can the industry transform itself with improved biomarkers for clinical development? And what hurdles stand in the way? We sat down with senior representatives from Galapagos, Ohio State University, and Genentech to find out more.
By Tia Byer |
25 February 2022
Biomarkers for Clinical Development
Commentary
Melanie Anderson, Principal Scientist at MSD, on how the pandemic has made scientists rethink clinical trials.
By Tom Cohen |
21 February 2022
Biomarkers for Clinical Development

Search by Keyword

Filter by Subject Area

Filter by Content Type

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login